Radio- and chemoprotection of bone marrow cells by opposite cell cycle-acting cytokines

Leukemia Research

Volumn 21, Issue 2, 1997, Pages 93-99

  Dalmau, S R ^a,b   Freitas, Claudia Sondermann ^a   Savino, W ^c  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^b STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Bone marrow; Chemoprotection; Cytokines; Precursor cells; Radioprotection

Indexed keywords

CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 12; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; RADIOSENSITIZING AGENT; STEM CELL FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; BONE MARROW CELL; CELL CYCLE; CELL PROTECTION; CONTROLLED STUDY; DETOXIFICATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION PROTECTION; REVIEW; STEM CELL;

EID: 0031079690     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(96)00052-5     Document Type: Editorial

References (67)

1. 1. Dalmau S. R., Freitas C. S. & Tabak D. G. (1993) Interleukin-1 and tumor necrosis factor-alpha as radio- and chemoprotectors of bone marrow. Bone Marrow Transplant 12, 551.
2. 2. Metcalf D. & Nicola N. A. (1991) Direct proliferative actions of stem cell factor on murine bone marrow cells in vitro: effects of combination with colony-stimulating factors. Proc. Natl. Acad. Sci. USA 88, 6239.
3. 3. de Vries P., Brasel K. A., Eisenman J. R., Alpert A. R. & Williams D. E. (1991) The effect of recombinant mast cell growth factor on purified hematopoietic stem cells. J. Exp. Med. 173, 1205.
4. 4. Muench M. O., Schneider J. G. & Moore M. A. S. (1991) Interactions among colony-stimulating factors, IL-1β, IL-6, and kit-ligand in the regulation of primitive murine hematopoietic cells. Exp. Hematol. 20, 339.
5. 5. Broxmeyer H. E., Maze R., Miazawa R., Carow C., Hendrie P. C., Cooper S., Hangoc G., Vadjan-Raj S. & Lu L. (1991) The kit receptor and its ligand, steel factor, as regulators of hemopoiesis. Cancer Cells 3, 480.
6. 6. Ogawa M., Matsuzaki Y., Nishikawa S., Hayashi S., Kunisada T., Sudo T., Kina T., Nakauchi H. & Nishikawa S. (1991) Expression and function of c-kit in hematopoietic progenitor cells. J. Exp. Med. 174, 63.
7. 7. Zsebo K. M., Smith K. A., Hartley C. A., Greenblatt M., Cooke K., Rich W. & McNiece I. K. (1992) Radioprotection of mice by recombinant rat stem cell factor. Proc. Natl Acad. Sci. USA 89, 9464.
8. 8. Neta R., Williams D., Seizer F. & Abrams J. (1993) Inhibition of c-kit ligand/steel factor by antibodies reduces survival of lethally-irradiated mice. Blood 81, 324.
9. 9. Neta R., Oppenheim J. J., Wang J.-M., Snapper C. M., Moorman M. A. & Dubois C. M. (1994) Synergy of IL-1 and stem cell factor in radioprotection of mice is associated with IL-1 up-regulation of mRNA and protein expression for c-kit on bone marrow cells. J. Immunol. 153, 1536.
10. 10. Neta R., Oppenheim J. J., Schreiber R. D., Chizzonite R., Ledney G. D. & Macvittie T. J. (1994) Role of cytokines (interleukin-1, tumor necrosis factor and transforming growth factor β in natural and lipopolysaccharide-enhanced radioresistance. J. Exp. Med. 173, 1177.
11. 11. Neta R., Stiefel S. M., Finkelman F., Herrmann S. & Ali N. Jr (1994) IL-12 protects bone marrow from and sensitizes intestinal tract to ionizing radiation. J. Immunol. 153, 4230.
12. 12. Trinchieri G. (1993) Interleukin-12 and its role in the generation of Th1 cells. Immunol. Today 14, 335.
13. 13. Jacobsen S. E. W., Veiby O. P. & Smeland O. B. (1993) Cytotoxic lymphocyte maturation factor (interleukin 12) is a synergistic growth factor for hematopoietic stem cells. J. Exp. Med. 178, 413.
14. 14. Ploemacher R. E., van Soest P. L., Voorvinder H. & Boudewijn A. (1993) Interleukin-12 synergizes with interleukin-3 and steel factor to enhance recovery of murine hematopoietic stem cells in liquid culture. Leukemia 7, 381.
15. 15. Hirayama F., Katayama N., Neben S., Donaldson D., Nickbarg E. B., Clark S. C. & Ogawa M. (1994) Synergistic interaction between interleukin-12 and steel factor in support of proliferation of murine lymphohematopoietic progenitors in culture. Blood 83, 92.
16. + human hematopoietic progenitor cells. J. Exp. Med. 180, 1177.
17. 17. Molineaux G., Migdalska A., Haley J., Evans G. S. & Dexter T. M. (1994) Total marrow failure induced by pegylated stem-cell factor administered before 5-fluorouracil. Blood 83, 3491.
18. 2 protect mice from acutely lethal doses of 5-fluorouracil and doxorubicin. J. Exp. Med. 180, 1047.
19. 19. Sing G. K., Keller J. R., Ellingsworth L. R. & Ruscetti F. W. (1988) Transforming growth factor β selectively inhibits normal and leukemic human bone marrow cell growth in vitro. Blood 72, 1504.
20. 20. Acton E. M., Tong G. L., Mosher C. W. & Wolgemouth R. L. (1984) Intensely potent morpholinyl antracyclines. J. Med. Chem. 27, 638.
21. + cells purified from cord blood and fetal liver. Exp. Hematol. 23, 422.
22. 22. Dunlop D. J., Wright E. G., Lorimore S., Graham G. J., Holyoake T., Kerr D. J., Wolpe S. D. & Pragnell I. B. (1992) Demonstration of stem cell inhibition and myeloprotective effects of SCI/rh MIP-1 alpha in vivo. Blood 79, 2221.
23. 23. Lord B. I., Dexter T. M., Clements J. M., Hunter M. A. & Gearing A. J. H. (1992) Macrophage-inflammatory protein protects multipotent hematopoietic cells from the cytotoxic effects of hydroxyurea in vivo. Blood 79, 2605.
24. 24. Quesniaux V. F. J., Graham G. J., Pragnell I., Donaldson D., Wolpe S. D., Iscove N. N. & Fagg B. (1993) Use of 5-fluorouracil to analyse the effect of macrophage inflammatory protein-1 alpha on long term reconstituting stem cells in vivo. Blood 81, 1497.
25. + hematopoietic progenitors from ultraviolet C. Exp. Hematol. 22, 742.
26. 26. Iliakis G. (1988) Radiation-induced potentially lethal damage DNA lesions susceptible to fixation. Int. J. Radiat. Biol. 53, 541.
27. 27. Denenkamp J. (1986) Cell kinetics and radiation biology. Int. J. Radiat. Biol. 49, 357.
28. 28. Neta R., Sztein M. B., Oppenheim J. J., Gillis S. & Douches S. D. (1987) The in vivo effects of interleukin 1. I. Bone marrow cells are induced to cycle after administration of interleukin 1. J. Immunol. 139, 1861.
29. 29. Lerner C. & Harrison D. E. (1990) 5-Fluorouracil spares hematopoiec stem cells responsible for long-term repopulation. Exp. Hematol. 18, 114.
30. 30. Moses H. L., Yang E. Y. & Pietenpol J. A. (1990) TGF-β stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 63, 245.
31. 31. Rusten L. S., Jacobson F. W., Smeland E. B. & Jacobsen S. E. W. (1994) Bifunctional effects of TNF-α in hematopoiesis: role of p55 and p75 TNF receptors. Exp. Hematol. 22, 720.
32. 32. Ottmann O. G. & Pelus L. M. (1988) Differential proliferative effects of transforming growth factor beta on human hematopoietic progenitor cells. J. Immunol. 140, 2661.
33. 33. Dubois C. M., Ruscetti F. W., Palaszynski E. W. & Falk L. A. (1990) Transforming growth factor β is a potent inhibitor of interleukin 1 (IL-1) receptor expression. Proposed mechanism of inhibition of IL-1 action. J. Exp. Med. 172, 737.
34. 34. Ploemacher R. E., van Soest P. L. & Boudewijn A. (1994) Differential effects of transforming growth factor (TGF β 1) on CFU-c production and colony formation by murine hemopoietic stem cells in serum-free medium stimulated by combinations of steel factor, IL-11, IL-12, G-CSF and IL-3. Exp. Hematol. 22, 739.
35. 35. Krystal G., Lam V., Dragowska W., Takahashi C., Appel J., Gontier A., Jenkins A., Lam H., Quan L. & Landsdorp P. (1994) Transforming growth factor β is an inducer of erytroid differentiation. Exp. Hematol. 22, 685.
36. 36. Welham M. J. & Schrader J. W. (1991) Modulation of c-kit mRNA and protein by hematopoietic growth factors. Mol. Cell. Biol. 11, 2901.
37. 37. Chudgar U. H., Rundus C. H. & Peterson V. M. (1995) Recombinant human interleukin-1 receptor antagonist protects early myeloid progenitors in a murine model of cyclophosphamide-induced myelotoxicity. Blood 85, 2393.
38. 38. Warren D. J., Slordal L. & Moore M. A. S. (1990) Tumor necrosis factor induces cell cycle arrest in multipotential haematopoietic stem cells - a possible radioprotective mechanism. Eur. J. Haematol. 45, 158.
39. 39. Neta R., Vogel S. N., Sipe J. D., Wong G. G. & Nordan R. P. (1988) Comparison of in vivo effects of human recombinant IL-1 and human recombinant IL-6 in mice. Lymphokine Res. 7, 403.
40. 40. Neta R., Douches S. D. & Oppenheim J. J. (1986) Interleukin-1 is a radioprotector. J. Immunol. 136, 2483.
41. 41. Neta R., Vogel S. N., Oppenheim J. J., Douches S. D., Giclas P. C., Imbra R. J. & Karin M. (1986) Radioprotection with interleukin-1: comparison with other cytokines. Prog. Immunol. 6, 900.
42. 42. Neta R., Vogel S. N., Oppenheim J. J. & Douches S. D. (1986) Cytokines in radioprotection: comparison of the radioprotective effects of IL-1 to IL-2, GM-CSF, and IFN-gamma. Lymphokine Res. 5, Suppl., S105.
43. 43. Wu S.-O. & Iyamoto T. (1990) Radioprotection of the intestinal crypts of mice by recombinant human interleukin-1 alpha. Radiat. Res. 123, 12.
44. 44. Dorie M., Allison A., Zaghloul M. & Kallman R. (1989) Interleukin-1 protects against lethal effect of irradiation of mice but has no effect on tumors in the same animal. Proc. Soc. Exp. Biol. Med. 191, 23.
45. 45. Castelli M. P., Black P. L., Schneider M., Pennington R., Abe F. & Talmadge J. E. (1988) Protective, restorative, and therapeutic properties of recombinant human IL-1 in rodent models. J. Immunol. 140, 3830.
46. 46. Futami H., Jansen R., Macphee M. J., Keller J., McCormick K., Longo D. L., Oppenheim J. J., Ruscetti F. W. & Wiltrout R. H. (1990) Chemoprotective effects of recombinant human IL-1α in cyclophosphamide treated normal and tumor-bearing mice. Protection from acute toxicity, hematologic effects, development of late mortality and enhanced therapeutic efficacy. J. Immunol. 145, 4121.
47. 47. Epstein D. A., Karahara C. G., Bruno N. A. & Terreli T. G. (1989) Prevention of doxorubicin-induced hematotoxicity in mice by IL-1. Cancer Res. 49, 3955.
48. 48. Homung R. L. & Longo D. L. (1992) Hematopoietic stem cell depletion by restorative growth factor regimens during repeated high-dose cyclophosphamide therapy. Blood 80, 77.
49. 49. Neta R., Prelstein R., Vogel S. N., Ledney G. D. & Abrams J. (1992) Role of IL-6 in protection from lethal radiation and in endocrine responses to IL-1 and TNF. J. Exp. Med. 175, 689.
50. 50. Neta R., Oppenheim J. J. & Douches S. D. (1988) Interdependence of the radioprotective effects of human recombinant interleukin 1α, tumor necrosis factor α, granulocyte colony-stimulating factor and murine recombinant granulocyte-macrophage colony-stimulating factor. J. Immunol. 140, 108.
51. 51. Slordal L., Warren D. J. & Moore M. A. S. (1989) Effect of recombinant murine tumor necrosis factor on hematopoietic reconstitution in sublethally irradiated mice. J. Immunol. 142, 833.
52. 52. Slordal L., Warren D. J. & Moore M. A. S. (1990) Protective effects of tumor necrosis factor on murine hematopoiesis during cycle specific cytotoxic chemotherapy. Cancer Res. 50, 4216.
53. 53. Jimenez J. J., Wong G. H. & Yunis A. A. (1991) Interleukin 1 protects from cytosine arabinoside-induced alopecia in the rat model. FASEB J. 5, 2456.
54. 54. Evans M. J., Kovaks W., Gooya J. M. & Harrel J. P. (1991) Interleukin-1β protects against the toxicity associated with combined radiation and drug therapy. Int. J. Radiat. Oncol. Biol. Phys. 20, 303.
55. 55. Zucali J., Zhang C., Picus R. & Moreb J. (1994) Protection of normal hematopoietic progenitors from L-phenylalanine mustard by interleukin 1. Exp. Hematol. 22, 742.
56. 56. Moreb J., Zucali J. R., Yhang Y., Colkin M. O. & Gross M. A. (1992) Role of aldehyde dehydrogenase in the protection of hematopoietic progenitor cells from 4-hydroperoxy cyclophosphamide by interleukin 1α and tumor necrosis factor. Cancer Res. 52, 1770.
57. 57. Constine L. S., Harwell S., Keng P., Lee F., Rubin P. & Siemman D. (1991) Interleukin 1 alpha stimulates hemopoiesis but not tumor cell proliferation and protects mice from lethal total body irradiation. Int. J. Radiat. Oncol. Biol. Phys. 20, 447.
58. 58. Grace H., Wong W. & Goeddel D. V. (1988) Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism. Science 242, 941.
59. 59. Crafford A. H., Derbin K. S., Hunte-McDonough B., Krauss M. R., Chen K. T., Smith D. M. & Epstein L. B. (1991) Manganese superoxide dismutase is induced by IFN-γ in multiple cell types. Synergistic induction by IFN-γ and tumor necrosis factor or IL-1. J. Immunol. 147, 149.
60. 60. Alaparthy S. & Zucali J. (1994) Overexpression of manganese superoxide dismutase promotes survival from adriamycin treatment. Exp. Hematol. 22, 700.
61. 61. Hong D. S., Huss R., Beckman C., Storb R. & Deeg W. (1994) Neutralization of c-kit ligand (stem cell factor) inhibits stromal cell function and induces hemopoietic differentiation. Exp. Hematol. 22, 737.
62. + cells in the absence of other growth factors. Exp. Hematol. 23, 413.
63. 63. Dubois C. M., Ruscetti F. W., Keller J. R., Oppenheim J. J., Hestdal K., Chizzonite R. & Neta R. (1991) In vivo interleukin-1 administration indirectly promotes type II IL-1 receptor expression in hematopoietic bone marrow cells: novel mechanism for the hematopoietic effects of IL-1. Blood 70, 2841.
64. 64. Kalechman Y., Zuloff A., Albeck M., Strassmann A. G. & Sredni B. (1995) Role of endogenous cytokine secretion in radioprotection conferred by the immunomodulator ammonium trichloro(dioxyethylene-O-O') tellurate. Blood 85, 1555.
65. 65. Goldenberg D. M., Larson S. M., Reisfeld R. A. & Schlom J. (1995) Targeting cancer with radiolabeled antibodies. Immunol. Today 16, 261.
66. 66. Chang C. M., Limanni A., Baker W. H., Kalinick J. F. & Patchen M. L. (1994) Effects of sublethal irradiation on IL-1α, IL-6 and TGF-β gene and protein expression in murine bone marrow and spleen: uncoupling in gene and protein expression. Exp. Hematol. 22, 751.
67. 67. Limanni A., Baker W. H., Chang C. M., Seeman R., Williams D. E. & Patchen M. L. (1995) c-kit ligand gene expression in normal and sublethally irradiated mice. Blood 85, 2377.